Viatris Competitors and Similar CompaniesClear all
Viatris's competitors and similar companies include Amgen, Sanofi, Teva Pharmaceuticals and Astellas Pharma.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. | ||
Founding Date | Founding Date 2020 | Founding Date 1980 | Founding Date 1994 | Founding Date 1901 | Founding Date 1923 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more |
Employees | Employees 38,0003% increase | Employees 25,200 | Employees 82,878 | Employees 37,000 | Employees 14,754 |
Valuation ($) | Valuation ($) 14 b | Valuation ($) 170.4 b | Valuation ($) 141.1 b | Valuation ($) 20.8 b | Valuation ($) 20.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods $12b (FY, 2025) | Cost of goods €11.6b (FY, 2025) | Cost of goods $8.3b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit $24.7b (FY, 2025) | Gross profit €37.6b (FY, 2025) | Gross profit $8.9b (FY, 2025) | Gross profit ¥2t (FY, 2026) |
Net income | Net income ($3.5b) (FY, 2025) | Net income $7.7b (FY, 2025) | Net income €8b (FY, 2025) | Net income $1.4b (FY, 2025) | Net income ¥291.6b (FY, 2026) |
Operating ⚠ | |||||
Countries | Countries 165 (Q1, 2023) | Countries 100 (FY, 2020) | Countries N/A | Countries N/A | Countries N/A |
Facilities | Facilities N/A | Facilities 180 (FY, 2020) | Facilities N/A | Facilities 90 (FY, 2019) | Facilities N/A |
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 9 (FY, 2021) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 1 (FY, 2020) |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 12 (FY, 2021) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 1 (FY, 2020) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 310m | Total funding raised $ 358m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Amgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companySanofi
HQ
Paris, FR
Employees
82,878
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000
Teva Pharmaceuticals is a global pharmaceutical company.
View companyAstellas Pharma
HQ
Tokyo, JP
Employees
14,754
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View company